In particular, we showed that mice with double deficiency of CathA and Scpep1 developed a persisted hypertension and demonstrated a prolonged half-life of circulating ET-1 as well as a more pronounced vasoconstriction in response to low pharmacological doses of this peptide[21]. The gene discussed is SCPEP1; the disease is Hypertension.